Kohmann Bosshard Financial Services LLC Takes Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Kohmann Bosshard Financial Services LLC purchased a new stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 579 shares of the company’s stock, valued at approximately $45,000.

Several other large investors have also modified their holdings of GEHC. Farther Finance Advisors LLC lifted its stake in shares of GE HealthCare Technologies by 10.9% in the 3rd quarter. Farther Finance Advisors LLC now owns 4,520 shares of the company’s stock valued at $424,000 after purchasing an additional 443 shares during the last quarter. Janney Capital Management LLC acquired a new position in shares of GE HealthCare Technologies in the 3rd quarter valued at $295,000. Janney Montgomery Scott LLC acquired a new position in shares of GE HealthCare Technologies in the 3rd quarter valued at $4,367,000. Forum Financial Management LP lifted its stake in shares of GE HealthCare Technologies by 5.4% in the 3rd quarter. Forum Financial Management LP now owns 6,084 shares of the company’s stock valued at $571,000 after purchasing an additional 314 shares during the last quarter. Finally, Intact Investment Management Inc. purchased a new stake in shares of GE HealthCare Technologies in the 3rd quarter valued at $73,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $86.45 on Tuesday. The stock’s 50-day moving average is $86.31 and its two-hundred day moving average is $86.14. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. GE HealthCare Technologies Inc. has a 1-year low of $74.51 and a 1-year high of $94.80. The company has a market cap of $39.53 billion, a price-to-earnings ratio of 19.97, a price-to-earnings-growth ratio of 3.19 and a beta of 1.15.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.19. The company had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. Analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

Wall Street Analyst Weigh In

GEHC has been the topic of several research analyst reports. Wells Fargo & Company boosted their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a report on Friday, February 14th. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their price objective for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. Finally, Citigroup boosted their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, February 13th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $97.67.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.